Adaptimmune Therapeutics (ADAP)
NASDAQ: ADAP
· Real-Time Price · USD
0.28
0.02 (5.78%)
At close: May 16, 2025, 3:59 PM
0.27
-3.19%
After-hours: May 16, 2025, 04:49 PM EDT
Adaptimmune Therapeutics Revenue
Adaptimmune Therapeutics reported an annual revenue of $178.03M, reflecting a 195.34% growth. For the quarter ending March 31, 2025, Adaptimmune Therapeutics generated $7.29M in revenue.
Revenue (ttm)
$178.03M
Revenue Growth
195.34%
Price / Sales Ratio
0.76
Revenue / Employee
$351.84K
Employees
506
Market Cap
71.91M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|